5.59
price up icon0.72%   0.04
after-market Handel nachbörslich: 5.59
loading
Schlusskurs vom Vortag:
$5.55
Offen:
$5.51
24-Stunden-Volumen:
3.41M
Relative Volume:
0.74
Marktkapitalisierung:
$1.72B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
111.80
EPS:
0.05
Netto-Cashflow:
$18.24M
1W Leistung:
+5.27%
1M Leistung:
+4.10%
6M Leistung:
+10.91%
1J Leistung:
-20.93%
1-Tages-Spanne:
Value
$5.46
$5.655
1-Wochen-Bereich:
Value
$5.244
$5.72
52-Wochen-Spanne:
Value
$3.3812
$7.63

Mannkind Corp Stock (MNKD) Company Profile

Name
Firmenname
Mannkind Corp
Name
Telefon
818-661-5000
Name
Adresse
1 CASPER STREET, DANBURY, CA
Name
Mitarbeiter
407
Name
Twitter
@MannKindCorp
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
MNKD's Discussions on Twitter

Vergleichen Sie MNKD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MNKD
Mannkind Corp
5.59 1.70B 248.37M 11.74M 18.24M 0.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Mannkind Corp Stock (MNKD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-20 Eingeleitet Wells Fargo Overweight
2025-10-10 Eingeleitet Leerink Partners Outperform
2025-07-16 Fortgesetzt H.C. Wainwright Buy
2025-04-10 Eingeleitet Mizuho Outperform
2025-02-10 Eingeleitet Wedbush Outperform
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-12-19 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-09-09 Fortgesetzt Leerink Partners Outperform
2024-06-13 Eingeleitet Rodman & Renshaw Buy
2023-10-10 Eingeleitet Wedbush Outperform
2021-05-14 Eingeleitet RBC Capital Mkts Sector Perform
2019-12-24 Eingeleitet Oppenheimer Outperform
2019-10-25 Eingeleitet Cantor Fitzgerald Overweight
2019-05-14 Eingeleitet BTIG Research Buy
2019-03-04 Eingeleitet SVB Leerink Outperform
2019-02-22 Eingeleitet SVB Leerink Outperform
2018-02-28 Herabstufung Maxim Group Hold → Sell
2017-11-01 Herabstufung Maxim Group Buy → Hold
2017-10-10 Eingeleitet H.C. Wainwright Buy
2017-10-06 Bestätigt Maxim Group Buy
2017-08-11 Eingeleitet Maxim Group Buy
2016-05-10 Bestätigt Piper Jaffray Underweight
2016-05-10 Bestätigt RBC Capital Mkts Underperform
2016-01-06 Bestätigt Piper Jaffray Underweight
2016-01-06 Bestätigt RBC Capital Mkts Underperform
2015-11-04 Herabstufung RBC Capital Mkts Outperform → Underperform
2015-09-09 Herabstufung Piper Jaffray Neutral → Underweight
2015-08-03 Bestätigt RBC Capital Mkts Outperform
2015-05-11 Herabstufung JP Morgan Neutral → Underweight
2015-05-11 Bestätigt MLV & Co Hold
2015-04-16 Bestätigt RBC Capital Mkts Outperform
Alle ansehen

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

pulisher
Nov 02, 2025

Technical signs of recovery in MannKind CorporationTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is MannKind Corporation (NNFN) stock undervalued after correction2025 Trading Recap & Growth Focused Entry Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will MannKind Corporation continue its uptrendBuy Signal & Momentum Based Trading Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Real time social sentiment graph for MannKind CorporationMarket Volume Summary & Target Return Focused Stock Picks - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can MannKind Corporation stock continue upward trend2025 Short Interest & Community Consensus Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

MannKind (MNKD) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

How MannKind Corporation stock responds to policy changes2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Is MannKind Corporation stock cheap compared to fundamentals2025 Key Lessons & Technical Pattern Based Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is MannKind Corporation (NNFN) stock undervalued historically2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is MannKind Corporation stock positioned well for digital economyJuly 2025 Big Picture & Safe Entry Momentum Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

MannKind Corporation to Announce Q3 2025 Financial Results and Host Webcast on November 5, 2025 - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 29, 2025

MannKind (Nasdaq: MNKD) to discuss third quarter 2025 results on Nov. 5 via webcast - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 29, 2025
pulisher
Oct 28, 2025

How analysts rate MannKind Corporation stock todayEarnings Growth Summary & Verified Stock Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can swing trading help recover from MannKind Corporation lossesProfit Target & AI Enhanced Trading Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How high can MannKind Corporation stock goJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Is MannKind Corporation stock attractive for retirement portfoliosQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will MannKind Corporation stock remain a Wall Street favorite2025 Price Action Summary & Weekly Sector Rotation Insights - fcp.pa.gov.br

Oct 27, 2025

Finanzdaten der Mannkind Corp-Aktie (MNKD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):